Sign In
to Vote &
Create Storyboards.
 
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD) -- medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions -- increased by 22 percent between 2006 and 2013 among individuals aged 0-24 years in Sweden, according to a new study.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard